Autobio Diagnostics Co., Ltd.

Shanghai Stock Exchange 603658.SS

Autobio Diagnostics Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -110.88 M

Autobio Diagnostics Co., Ltd. Net Cash Used For Investing Activities is USD -110.88 M for the year ending December 31, 2023, a 21.82% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Autobio Diagnostics Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -141.82 M, a -76.41% change year over year.
Autobio Diagnostics Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -80.39 M, a 84.94% change year over year.
Autobio Diagnostics Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -533.74 M, a -201.04% change year over year.
Autobio Diagnostics Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -177.30 M, a -252.87% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Shanghai Stock Exchange: 603658.SS

Autobio Diagnostics Co., Ltd.

CEO	Mr. Rui Kuan Fang
IPO Date	Sept. 2, 2016
Location	China
Headquarters	No. 199, 15th Avenue
Employees	5,539
Sector	Health Care
Industries Biotechnology Medical Instruments Pharmaceuticals

Description

Autobio Diagnostics Co., Ltd. engages in the research and development, production, and distribution of clinical diagnostic products. It develops immunoassay, biochemistry, microbiology, and IVD reagents; and instruments, such as automation and semi-automation systems, as well as medical laboratory solutions. The company's immunoassay products AutoLumo A2000 Plus, an automatic Chemiluminescence immunoassay analyzer; automatic microplate chemiluminescent enzyme immunoassay; and LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Its microbiology products comprise automated blood culture systems; blood culture bottles; AUTOMIC strips; and mycoplasma IES. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is based in Zhengzhou, China. Autobio Diagnostics Co., Ltd. is a subsidiary of Zhengzhou Auto Industrial Co., Ltd.

Key trends

Past 5 years